Assessment of the prognostic significance of positron emission tomography combined with computed tomography at different stages of treatment in patients with non-Hodgkin lymphomas: a cohort study
Kazan medical journal · 29.05.2026 · 107 (3) · 471-478
DOI: 10.17816/kmj697071 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Kazan medical journal, online erschienen am 29.05.2026. Verfasst von Foat Sh. Akhmetzyanov und 2 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
The Russian Federation is experiencing an increase in the incidence of tumors of lymphoid and hematopoietic tissues; however, no unified diagnostic or treatment algorithm has been developed for these conditions.
Aim
To determine effective diagnostic and therapeutic approaches, as well as criteria for early treatment adaptation, in patients with nonHodgkin lymphomas.
Methods
The medical records of 439 patients with two histological types of nonHodgkin lymphomas who received inpatient treatment and followup at the Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan over a 10year period were retrospectively reviewed: 386 patients with aggressive lymphoma (diffuse large Bcell lymphoma) and 53 patients with indolent lymphoma (follicular lymphoma). There were 237 patients (54.0%) aged over 60 years and 89 (20.2%) aged over 70 years. A total of 259 patients underwent three positron emission tomography combined with computed tomography (PET/CT) scans (primary, interim, and final). Inclusion criteria were: age ≥18 years; no prior treatment for nonHodgkin lymphoma; and a histologically and immunohistochemically confirmed diagnosis. Exclusion criteria were: acute somatic or infectious diseases (including HIV infection) ; severe cognitive impairment; refusal to participate in the study; and residence outside the region. Statistical analysis was performed using IBM SPSS Statistics and Statistica 10 software. Normality of distribution was tested using the Kolmogorov–Smirnov test. Survival was assessed using the Kaplan–Meier method. Differences were considered statistically significant at р 0.05.
Results
Changes in the maximum standardized uptake value (SUVmax) on interim PET/CT were shown to be associated with the risk of progression and with overall survival rates, which decreased significantly with increasing disease stage. Assessment of the metabolic response at the interim stage using the Deauville scale demonstrated high prognostic significance: scores of 1–3 identified a group of patients with complete metabolic remission. However, even when a pronounced tumor response was achieved, some patients developed severe cumulative toxicity. Specifically, in a group of 120 patients who continued treatment after the fourth cycle, highgrade febrile neutropenia was recorded in 11 patients (9.2%), and in 10 of these cases (8.3%) it was accompanied by fatal complications due to multiple organ failure.
Conclusion
These findings underscore that in patients who achieve a complete metabolic response but have signs of severe cumulative toxicity, reducing the planned volume of chemotherapy should be considered to improve treatment safety.
Zitieren
APA
Akhmetzyanov, F. S., Boichuk, S. V., & Karamanian, A. V. (2026). Assessment of the prognostic significance of positron emission tomography combined with computed tomography at different stages of treatment in patients with non-Hodgkin lymphomas: a cohort study. Kazan medical journal, 107(3), 471-478. https://doi.org/10.17816/kmj697071
Vancouver
Akhmetzyanov FS, Boichuk SV, Karamanian AV. Assessment of the prognostic significance of positron emission tomography combined with computed tomography at different stages of treatment in patients with non-Hodgkin lymphomas: a cohort study. Kazan medical journal. 2026;107(3):471-478. doi:10.17816/kmj697071
BibTeX
@article{Akhmetzyanov2026,
author = {Akhmetzyanov, Foat Sh. and Boichuk, Sergey V. and Karamanian, Angelina V.},
title = {Assessment of the prognostic significance of positron emission tomography combined with computed tomography at different stages of treatment in patients with non-Hodgkin lymphomas: a cohort study},
journal = {Kazan medical journal},
year = {2026},
volume = {107},
number = {3},
pages = {471--478},
doi = {10.17816/kmj697071}
}
EUVIMED